Lv1
100 积分 2026-09-02 加入
Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations
1个月前
已完结
Elevated lipoprotein(a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: A cohort study from the UK Biobank
1个月前
已完结
Multi-Ethnic Study of Atherosclerosis (MESA)
1个月前
已完结
The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus
1个月前
已完结
Bioactive lipids in plasma and atherogenic apoB-containing lipoproteins: Effects of statins and PCSK9 inhibitors and relevance to residual cardiovascular risk
1个月前
已完结
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
1个月前
已完结
Atherosclerotic Cardiovascular Disease in Diabetes Patients
1个月前
已完结
皖公网安备34019202002308
